Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             43 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A candidate phocid herpesvirus vaccine that provides protection against feline herpesvirus infection Martina, Byron E.E.
2001
20 5-6 p. 943-948
6 p.
artikel
2 A human volunteer challenge model using frozen bacteria of the new epidemic serotype, V. cholerae O139 in Thai volunteers Pitisuttithum, Punnee
2001
20 5-6 p. 920-925
6 p.
artikel
3 Anthrax vaccine: short-term safety experience in humans Pittman, Phillip R
2001
20 5-6 p. 972-978
7 p.
artikel
4 Antibodies to Plasmodium vivax transmission-blocking vaccine candidate antigens Pvs25 and Pvs28 do not show synergism Hisaeda, Hajime
2001
20 5-6 p. 763-770
8 p.
artikel
5 Cold-attenuated live influenza vaccines, a risk-benefit assessment Pfleiderer, Michael
2001
20 5-6 p. 886-894
9 p.
artikel
6 Conversion of poorly immunogenic malaria repeat sequences into a highly immunogenic vaccine candidate Milich, David R
2001
20 5-6 p. 771-788
18 p.
artikel
7 Corrigendum to “Reactogenicity and immunogenicity of adult versus paediatric diptheria and tetanus booster dose at 6 years of age” [Vaccine 20 (2002) 74–79] Ciofi degli Atti, M.L.
2001
20 5-6 p. 989-
1 p.
artikel
8 Cross-clade neutralizing antibody production against human immunodeficiency virus type 1 clade E and B′ strains by recombinant Mycobacterium bovis BCG-based candidate vaccine Chujoh, Yoshitomo
2001
20 5-6 p. 797-804
8 p.
artikel
9 Current overview of the pathogenesis and prophylaxis of measles with focus on practical implications Hilleman, Maurice R
2001
20 5-6 p. 651-665
15 p.
artikel
10 Effect of influenza immunization on CYP3A4 activity Hayney, Mary S.
2001
20 5-6 p. 858-861
4 p.
artikel
11 Enhanced activation of rhesus T cells by vectors encoding a triad of costimulatory molecules (B7-1, ICAM-1, LFA-3) Shankar, Pragyna
2001
20 5-6 p. 744-755
12 p.
artikel
12 Enhanced CD8+ T cell immune response against a V3 loop multi-epitope polypeptide (TAB13) of HIV-1 Env after priming with purified fusion protein and booster with modified vaccinia virus Ankara (MVA-TAB) recombinant: a comparison of humoral and cellular immune responses with the vaccinia virus Western Reserve (WR) vector Gómez, Carmen Elena
2001
20 5-6 p. 961-971
11 p.
artikel
13 Erratum to “Developing Country Vaccine Manufacturers Network (DCVMN), 26–27 April 2001, Bandung, Indonesia” [Vaccine 20 (2002) 285–287] Poeloengan, Thamrin
2001
20 5-6 p. 990-
1 p.
artikel
14 Expression of the B-cell and T-cell epitopes of the rabies virus nucleoprotein in Mycobacterium bovis BCG and induction of an humoral response in mice da Cruz, Flávia W.
2001
20 5-6 p. 731-736
6 p.
artikel
15 Frequent occurrence of hepatitis B virus surface antigen mutants in subtype adw in vaccinated Singapore infants Chen, Wei Ning
2001
20 5-6 p. 639-640
2 p.
artikel
16 Highly purified mutant E112K of cholera toxin elicits protective lung mucosal immunity to diphtheria toxin Ohmura, Mari
2001
20 5-6 p. 756-762
7 p.
artikel
17 Immune response induced by recombinant BCG expressing merozoite surface antigen 2 from Plasmodium falciparum Zheng, Chunfu
2001
20 5-6 p. 914-919
6 p.
artikel
18 Immunization with a portion of rickettsial outer membrane protein A stimulates protective immunity against spotted fever rickettsiosis Crocquet-Valdes, P.A
2001
20 5-6 p. 979-988
10 p.
artikel
19 Immunogenicity and protective efficacy of a vaccine prepared from 53 kDa truncated hepatitis E virus capsid protein expressed in insect cells Zhang, Mingdong
2001
20 5-6 p. 853-857
5 p.
artikel
20 Immunologic and virologic response after tetanus toxoid booster among HIV-1- and HIV-2-infected Senegalese individuals Dieye, Tandakha Ndiaye
2001
20 5-6 p. 905-913
9 p.
artikel
21 Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells treated with an anthrax toxin fusion protein Moriya, Osamu
2001
20 5-6 p. 789-796
8 p.
artikel
22 Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation Munoz, Flor M.
2001
20 5-6 p. 826-837
12 p.
artikel
23 Materno-foetal transfer of H. influenzae and pneumococcal antibodies is influenced by prematurity and low birth weight: implications for conjugate vaccine trials Okoko, Brown J
2001
20 5-6 p. 647-650
4 p.
artikel
24 One-time gene gun or intramuscular rabies DNA vaccination of non-human primates: comparison of neutralizing antibody responses and protection against rabies virus 1 year after vaccination Lodmell, Donald L.
2001
20 5-6 p. 838-844
7 p.
artikel
25 Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy Liu, Wen Jun
2001
20 5-6 p. 862-869
8 p.
artikel
26 ProJuvant™ (Pluronic F127®/chitosan) enhances the immune response to intranasally administered tetanus toxoid Julie Westerink, M.A
2001
20 5-6 p. 711-723
13 p.
artikel
27 Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model Nehete, Pramod N
2001
20 5-6 p. 813-825
13 p.
artikel
28 Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus Wu, Cheng-Nan
2001
20 5-6 p. 895-904
10 p.
artikel
29 PsaA (pneumococcal surface adhesin A) and PspA (pneumococcal surface protein A) DNA vaccines induce humoral and cellular immune responses against Streptococcus pneumoniae Miyaji, Eliane N.
2001
20 5-6 p. 805-812
8 p.
artikel
30 Quantifying the population impact of a prophylactic Helicobacter pylori vaccine Rupnow, Marcia F.T.
2001
20 5-6 p. 879-885
7 p.
artikel
31 Recombinant paramyosin (rec-Sj-97) tested for immunogenicity and vaccine efficacy against Schistosoma japonicum in mice and water buffaloes McManus, Donald P.
2001
20 5-6 p. 870-878
9 p.
artikel
32 Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration Campins-Martı́, M.
2001
20 5-6 p. 641-646
6 p.
artikel
33 Respiratory syncytial virus vaccine: a systematic overview with emphasis on respiratory syncytial virus subunit vaccines Simoes, Eric A.F
2001
20 5-6 p. 954-960
7 p.
artikel
34 Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers Bumann, D
2001
20 5-6 p. 845-852
8 p.
artikel
35 Safety evaluation of a glutaraldehyde modified tyrosine adsorbed housedust mite extract containing monophosphoryl lipid A (MPL®) adjuvant: a new allergy vaccine for dust mite allergy Baldrick, Paul
2001
20 5-6 p. 737-743
7 p.
artikel
36 T-cell vaccination for autoimmune disease: a panorama Cohen, Irun R.
2001
20 5-6 p. 706-710
5 p.
artikel
37 Tetanus toxin fragment C-specific priming by intranasal infection with recombinant Bordetella pertussis Reveneau, Nathalie
2001
20 5-6 p. 926-933
8 p.
artikel
38 The basis for HIV immunotherapeutic vaccines Peters, B.S.
2001
20 5-6 p. 688-705
18 p.
artikel
39 The costs of an outbreak—an example from a Danish day care setting Fischer, T.K.
2001
20 5-6 p. 637-638
2 p.
artikel
40 The frailty hypothesis revisited: mainly weak children die of measles Aaby, Peter
2001
20 5-6 p. 949-953
5 p.
artikel
41 Use of fusion protein constructs to generate potent immunotherapy and protection against scorpion toxins Legros, Christian
2001
20 5-6 p. 934-942
9 p.
artikel
42 Vaccination of mice with a cocktail DNA vaccine induces a Th1-type immune response and partial protection against Schistosoma japonicum infection Zhang, Yaobi
2001
20 5-6 p. 724-730
7 p.
artikel
43 Vaccine prevention of meningococcal disease, coming soon? Morley, Sarah L.
2001
20 5-6 p. 666-687
22 p.
artikel
                             43 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland